SG11201705125UA - Polymyxin derivative and uses thereof - Google Patents
Polymyxin derivative and uses thereofInfo
- Publication number
- SG11201705125UA SG11201705125UA SG11201705125UA SG11201705125UA SG11201705125UA SG 11201705125U A SG11201705125U A SG 11201705125UA SG 11201705125U A SG11201705125U A SG 11201705125UA SG 11201705125U A SG11201705125U A SG 11201705125UA SG 11201705125U A SG11201705125U A SG 11201705125UA
- Authority
- SG
- Singapore
- Prior art keywords
- polymyxin derivative
- polymyxin
- derivative
- Prior art date
Links
- 108010040201 Polymyxins Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20155027A FI126143B (en) | 2015-01-15 | 2015-01-15 | Polymyxin derivatives and uses thereof |
| PCT/FI2016/050016 WO2016113470A1 (en) | 2015-01-15 | 2016-01-15 | Polymyxin derivative and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705125UA true SG11201705125UA (en) | 2017-07-28 |
Family
ID=55310836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705125UA SG11201705125UA (en) | 2015-01-15 | 2016-01-15 | Polymyxin derivative and uses thereof |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP3045469B1 (en) |
| JP (1) | JP6471236B2 (en) |
| KR (1) | KR102020886B1 (en) |
| CN (1) | CN107207569B (en) |
| AU (1) | AU2016207942B2 (en) |
| BR (1) | BR112017014670A2 (en) |
| CA (1) | CA2972743C (en) |
| DK (1) | DK3045469T3 (en) |
| ES (1) | ES2656562T3 (en) |
| FI (1) | FI126143B (en) |
| HR (1) | HRP20180180T1 (en) |
| HU (1) | HUE035778T2 (en) |
| IL (1) | IL253457B (en) |
| MX (1) | MX2017009094A (en) |
| NO (1) | NO3045469T3 (en) |
| PT (1) | PT3045469T (en) |
| RU (1) | RU2675819C1 (en) |
| SG (1) | SG11201705125UA (en) |
| TW (1) | TWI694087B (en) |
| WO (1) | WO2016113470A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110072878B (en) * | 2016-12-16 | 2021-07-23 | 中国医学科学院医药生物技术研究所 | Polymyxin derivatives, preparation method and application thereof |
| GB201703898D0 (en) | 2017-03-10 | 2017-04-26 | Helperby Therapeautics Ltd | Method |
| GB201704620D0 (en) | 2017-03-23 | 2017-05-10 | Helperby Therapeautics Ltd | Combinations |
| CN107661349A (en) * | 2017-11-24 | 2018-02-06 | 刘晓峰 | A kind of combination medicine for treating infantile hyperpyrexia |
| CN110179967A (en) * | 2019-05-28 | 2019-08-30 | 中国医药集团总公司四川抗菌素工业研究所 | The composition and its application of polymyxins parent nucleus and a kind of antibiotic |
| IT201900025414A1 (en) | 2019-12-23 | 2021-06-23 | Univ Bologna Alma Mater Studiorum | COMPOUND FOR THE TREATMENT OF UREMIC HEMOLITIC SYNDROME |
| CN117083288A (en) * | 2021-03-31 | 2023-11-17 | 江苏奥赛康药业有限公司 | Sulfate of polymyxin derivative and pharmaceutical composition thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754411A (en) * | 1969-08-05 | 1971-02-04 | Rhone Poulenc Sa | CYCLOPEPTIDES DERIVED FROM POLYMYXINS AND THEIR |
| TW274552B (en) * | 1992-05-26 | 1996-04-21 | Hoechst Ag | |
| US20060004185A1 (en) * | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
| CA2694289C (en) * | 2006-08-11 | 2015-04-07 | Northern Antibiotics Oy | Polymyxin derivatives and uses thereof |
| US7807637B2 (en) | 2006-08-11 | 2010-10-05 | Northern Antibiotics Oy | Polymyxin derivatives and uses thereof |
| FI20085469A0 (en) * | 2008-02-08 | 2008-05-16 | Northern Antibiotics Oy | Polymyxin derivatives with short fatty acid tails and their uses |
| WO2013072695A1 (en) | 2011-11-18 | 2013-05-23 | Novacta Biosystems Limited | Polymyxin derivatives |
| US10640536B2 (en) * | 2013-01-11 | 2020-05-05 | Xellia Pharmaceuticals Aps | Polymyxins, compositions, methods of making and methods of use |
| BR112015029309A2 (en) | 2013-05-22 | 2017-07-25 | New Pharma Licence Holdings Ltd | polymyxin derivatives and their use in combination therapy with different antibiotics |
-
2015
- 2015-01-15 FI FI20155027A patent/FI126143B/en active IP Right Grant
-
2016
- 2016-01-15 JP JP2017536921A patent/JP6471236B2/en active Active
- 2016-01-15 DK DK16151398.1T patent/DK3045469T3/en active
- 2016-01-15 AU AU2016207942A patent/AU2016207942B2/en active Active
- 2016-01-15 KR KR1020177022255A patent/KR102020886B1/en active IP Right Grant
- 2016-01-15 CA CA2972743A patent/CA2972743C/en active Active
- 2016-01-15 RU RU2017127011A patent/RU2675819C1/en active
- 2016-01-15 BR BR112017014670-3A patent/BR112017014670A2/en active IP Right Grant
- 2016-01-15 CN CN201680005506.9A patent/CN107207569B/en active Active
- 2016-01-15 EP EP16151398.1A patent/EP3045469B1/en active Active
- 2016-01-15 SG SG11201705125UA patent/SG11201705125UA/en unknown
- 2016-01-15 ES ES16151398.1T patent/ES2656562T3/en active Active
- 2016-01-15 MX MX2017009094A patent/MX2017009094A/en active IP Right Grant
- 2016-01-15 NO NO16151398A patent/NO3045469T3/no unknown
- 2016-01-15 TW TW105101251A patent/TWI694087B/en active
- 2016-01-15 PT PT161513981T patent/PT3045469T/en unknown
- 2016-01-15 WO PCT/FI2016/050016 patent/WO2016113470A1/en active Application Filing
- 2016-01-15 HU HUE16151398A patent/HUE035778T2/en unknown
-
2017
- 2017-07-12 IL IL25345717A patent/IL253457B/en active IP Right Grant
-
2018
- 2018-01-31 HR HRP20180180TT patent/HRP20180180T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK3045469T3 (en) | 2018-03-05 |
| IL253457A0 (en) | 2017-09-28 |
| WO2016113470A1 (en) | 2016-07-21 |
| CN107207569B (en) | 2020-11-03 |
| HRP20180180T1 (en) | 2018-03-09 |
| KR20170102005A (en) | 2017-09-06 |
| JP6471236B2 (en) | 2019-02-13 |
| BR112017014670A2 (en) | 2018-03-13 |
| ES2656562T3 (en) | 2018-02-27 |
| NO3045469T3 (en) | 2018-04-28 |
| CA2972743A1 (en) | 2016-07-21 |
| EP3045469B1 (en) | 2017-11-29 |
| KR102020886B1 (en) | 2019-09-16 |
| JP2018505868A (en) | 2018-03-01 |
| HUE035778T2 (en) | 2018-08-28 |
| RU2675819C1 (en) | 2018-12-25 |
| TWI694087B (en) | 2020-05-21 |
| IL253457B (en) | 2019-10-31 |
| CA2972743C (en) | 2020-06-09 |
| FI126143B (en) | 2016-07-15 |
| EP3045469A1 (en) | 2016-07-20 |
| AU2016207942A1 (en) | 2017-08-10 |
| PT3045469T (en) | 2018-02-08 |
| TW201630930A (en) | 2016-09-01 |
| AU2016207942B2 (en) | 2018-05-10 |
| FI20155027A (en) | 2016-07-15 |
| CN107207569A (en) | 2017-09-26 |
| MX2017009094A (en) | 2018-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1231471A1 (en) | 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof 6-- 6--2- | |
| IL252216A0 (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
| PL3152226T3 (en) | Modified cyclopentapeptides and uses thereof | |
| PL3188641T3 (en) | Holding assembly | |
| IL253457B (en) | Polymyxin derivative and uses thereof | |
| SG11201704473WA (en) | New methods and uses | |
| HK1247122A1 (en) | Combinations and uses thereof | |
| IL254241A0 (en) | Etv2 and uses thereof | |
| GB201421452D0 (en) | Exhaust assembly | |
| GB201419650D0 (en) | Modified heterocyclase | |
| GB201408091D0 (en) | Methods and uses | |
| IL250719B (en) | Luminaire and luminaire components | |
| GB2522661B (en) | Context configuration | |
| GB201621467D0 (en) | Modified bulgeomers | |
| GB201616374D0 (en) | Modified bulgeomers | |
| GB201614858D0 (en) | Modified Bulgeomers | |
| GB201416073D0 (en) | Methods and uses | |
| GB201416086D0 (en) | Methods and uses | |
| GB201404728D0 (en) | Disc-over incorporating disc-heads and disc-earning | |
| GB201404301D0 (en) | Compounds and combinations | |
| GB201407596D0 (en) | New compounds and uses | |
| GB201407599D0 (en) | New compounds and uses | |
| GB201408122D0 (en) | Case fit | |
| GB201402467D0 (en) | New Compounds and uses |